Drugs of Abuse Testing Markets: Forecasts to 2018 (Lab-Based, Professional POC, Home, Employment, Criminal Justice Markets)
|出版日期||內容資訊||英文 150 Pages
|藥物濫用檢測市場(實驗室用、醫療POC、家庭用、僱用處、刑警司法) Drugs of Abuse Testing Markets: Forecasts to 2018 (Lab-Based, Professional POC, Home, Employment, Criminal Justice Markets)|
|出版日期: 2014年07月14日||內容資訊: 英文 150 Pages||
Drugs of Abuse is an important growth category in IVD testing with competitive participation by top IVD vendors for market share. Healthcare professionals, employers, criminal justice personnel, and sports use drug tests as part of a comprehensive evaluation of individuals to reach a correct decision regarding the individuals' actions, behaviors or performances. This report covers trends and markets in drugs of abuse testing. As part of its coverage, the report offers estimates and forecasts for drugs of abuse markets, and the following market segment estimates:
The report's geographic scope is worldwide with information for specific geographical regions; world demographics;, and other general issues affecting the market The market summary includes market analysis by product and region and a competitive analysis of leading providers. Additionally, key company profiles are included. The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals.
Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study, Kalorama Information conducted interviews with more than 12 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.
A group of diversified companies is involved in the development or marketing of drugs of abuse testing and technology products. The market is considered evolving with growth opportunity. Drug abuse is a worldwide problem and it is growing. Key companies such as Roche Diagnostics, Abbott Diagnostics and Siemens Healthcare will likely maintain leading positions in the market through continued product innovation and strategic alliances and mergers.
Among the top and/or innovative competitors discussed within Corporate Profiles are:
There are many different methods of testing for drugs. There is no single best method. In selecting the testing method that will produce the best analyses, three factors are considered:
Immunoassays are common in clinical laboratories. Some of those most frequently used include latex agglutination tests, radioimmunoassay (RIA), fluorescence polarization, immunoassay (performed on the Abbott Tex and related instruments), and enzyme-multiplied immunoassay technique (EMIT), a trademark of the Syva Corporation. These tests are completely specific.
Latex agglutination tests are examples of tests that can conveniently be performed on an occasional basis in a POL. They are too expensive for large-volume work, but require no instrumentation. Their use is generally confined to urine specimens.
Lateral flow tests also known as lateral flow immunochromatographic assays, are simple devices intended to detect the presence (or absence) of a target analyte in the sample (matrix) without the need for specialized and costly equipment, though many lab based applications exist that are supported by reading equipment. Typically, these tests are used for medical diagnostics either for home testing, point of care testing, or laboratory use. The technology is based on a series of capillary beds, such as pieces of porous paper or sintered polymer. Each of these elements has the capacity to transport fluid (e.g., urine) spontaneously.
Radioimmunoassay is usually a manual test. It is satisfactory for use on blood as well as other body fluids and is widely used in forensic toxicology laboratories.
Thin-layer chromatography is well suited for simultaneous screening of urine specimens for hundreds of drugs. Results are qualitative only, and the test is not extremely sensitive. It is best used for testing specimens from hospital emergency rooms, but is not widely available because of the technical expertise required to perform the test. Drugs are extracted from the specimens to be tested, concentrated, and applied to the bottom of a strip of paper or other permeable material. The bottom of the strip is then immersed in a solvent inside a closed container. As the solvent travels up the paper, drugs are carried along at different rates and separated. After drying the chromagram, the drugs may be visualized as colored spots by spraying with various chemicals.